Clinical trial
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee…
NCT00331838 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00331838 |
|---|---|
| Title | Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery |
| Official title | A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel Group, Dose Response Study of Subcutaneous AVE5026 With an Enoxaparin Calibrator Arm in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery |
| Acronym | TREK |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Venous Thromboembolism |
| Intervention type | Drug |
| Interventions | Semuloparin sodium, Placebo (for Enoxaparin sodium), Enoxaparin sodium, Placebo (for Semuloparin sodium) |
| Enrollment | 705 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | May 31, 2006 |
| Last update posted | Jan 15, 2013 |
| Countries | Argentina, Bulgaria, Chile, Colombia, Denmark, Finland, Greece, Malaysia, Mexico, Norway, Philippines, Poland and 7 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: